Deschamps C, Tirnaksiz B M, Darbandi R, Trastek V F, Allen M S, Miller D L, Arnold P G, Pairolero P C
Section of General Thoracic Surgery and Division of Plastic and Reconstructive Surgery, Mayo Clinic and Mayo Foundation, Rochester, MN, USA.
J Thorac Cardiovasc Surg. 1999 Mar;117(3):588-91; discussion 591-2. doi: 10.1016/s0022-5223(99)70339-9.
The purpose of this report is to evaluate our results in patients who underwent prosthetic bony reconstruction after chest wall resection.
We retrospectively reviewed all patients who underwent chest wall resection and reconstruction with prosthetic material at the Mayo Clinic.
From January 1, 1977, to December 31, 1992, 197 patients (109 male patients and 88 female patients) underwent chest wall resection and reconstruction with prosthetic material. Median age was 59 years (range, 11-86 years). The indication for resection was recurrent chest wall malignancy in 65 patients (33.0%), primary chest wall malignancy in 62 patients (31.5%), contiguous lung or breast carcinoma in 58 patients (29.4%), and other reasons in 12 patients (6.1%). Three patients (1.5%) each had an open draining wound. This review covers 2 time periods. Sixty-four patients (32.5%) underwent reconstruction with polypropylene mesh during the period from 1977 to 1986. One hundred thirty-three patients (67.5%) underwent reconstruction with polytetrafluoroethylene from 1984 to 1992. Soft tissue coverage was achieved with transposed muscle in 116 patients (58.9%), local tissue in 81 patients (41.1%), and omentum in 3 patients (1.5%). There were 8 deaths (operative mortality rate, 4.1%). Ninety-one patients (46.2%) experienced complications. Seromas occurred in 14 patients (7.1%). Wound infections occurred in 9 patients (4.6%; 5 patients with polypropylene mesh and 4 patients with polytetrafluoroethylene). The prosthesis was removed in all 5 patients with polypropylene mesh and in none of the patients with polytetrafluoroethylene. Follow-up was complete in 179 operative survivors (94.7%) and ranged from 1 to 204 months (median, 26 months). A well-healed asymptomatic wound was present in 127 patients (70.9%).
Chest wall resection and reconstruction with prosthetic material will yield satisfactory results in most patients. Little difference exists between polypropylene mesh and polytetrafluoroethylene.
本报告旨在评估接受胸壁切除术后假体骨重建患者的治疗结果。
我们回顾性分析了梅奥诊所所有接受胸壁切除并用假体材料重建的患者。
1977年1月1日至1992年12月31日,197例患者(109例男性患者和88例女性患者)接受了胸壁切除并用假体材料重建。中位年龄为59岁(范围11 - 86岁)。切除的指征为65例(33.0%)复发性胸壁恶性肿瘤、62例(31.5%)原发性胸壁恶性肿瘤、58例(29.4%)相邻肺或乳腺癌以及12例(6.1%)其他原因。3例患者(1.5%)各有一个开放引流伤口。本回顾涵盖两个时间段。1977年至1986年期间,64例患者(32.5%)用聚丙烯网片进行重建。1984年至1992年期间,133例患者(67.5%)用聚四氟乙烯进行重建。116例患者(58.9%)通过转移肌瓣实现软组织覆盖,81例患者(41.1%)通过局部组织覆盖,3例患者(1.5%)通过大网膜覆盖。有8例死亡(手术死亡率4.1%)。91例患者(46.2%)出现并发症。14例患者(7.1%)发生血清肿。9例患者(4.6%;5例使用聚丙烯网片,4例使用聚四氟乙烯)发生伤口感染。使用聚丙烯网片患者中的5例全部取出假体,而使用聚四氟乙烯的患者无一取出。179例手术存活者(94.7%)获得完整随访,随访时间为1至204个月(中位时间26个月)。127例患者(70.9%)伤口愈合良好且无症状。
胸壁切除并用假体材料重建在大多数患者中可取得满意结果。聚丙烯网片和聚四氟乙烯之间差异不大。